BlackRock Inc. bought a new stake in AdvanSix (NYSE:ASIX - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,440,480 shares of the company's stock, valued at approximately $48,517,000. BlackRock Inc. owned about 9.05% of AdvanSix at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Aegis Financial Corp acquired a new stake in AdvanSix in the 4th quarter valued at approximately $20,927,000. Millennium Management LLC purchased a new stake in AdvanSix in the fourth quarter valued at approximately $11,479,000. Alliancebernstein L.P. lifted its stake in AdvanSix by 55.3% during the third quarter. Alliancebernstein L.P. now owns 948,491 shares of the company's stock worth $18,382,000 after purchasing an additional 337,908 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in AdvanSix by 78.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 728,292 shares of the company's stock worth $17,770,000 after purchasing an additional 319,528 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of AdvanSix by 149.3% during the fourth quarter. Goldman Sachs Group Inc. now owns 378,610 shares of the company's stock worth $6,550,000 after buying an additional 226,756 shares during the period. Hedge funds and other institutional investors own 86.39% of the company's stock.
AdvanSix Price Performance
ASIX stock opened at $16.81 on Tuesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.28 and a quick ratio of 0.70. The firm has a market capitalization of $453.87 million, a P/E ratio of -25.47 and a beta of 1.29. The business's 50-day moving average is $19.12 and its two-hundred day moving average is $20.76. AdvanSix has a 1 year low of $14.10 and a 1 year high of $26.73.
AdvanSix (NYSE:ASIX - Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.56 by ($0.37). The company had revenue of $421.28 million for the quarter, compared to analyst estimates of $452.00 million. AdvanSix had a negative return on equity of 1.28% and a negative net margin of 1.14%. Analysts anticipate that AdvanSix will post -0.15 earnings per share for the current fiscal year.
AdvanSix Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Tuesday, August 18th will be given a $0.16 dividend. The ex-dividend date of this dividend is Tuesday, August 18th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.8%. AdvanSix's dividend payout ratio is currently -96.97%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Zacks Research raised AdvanSix to a "hold" rating in a research note on Tuesday, May 12th. Weiss Ratings cut AdvanSix from a "sell (d+)" rating to a "sell (d)" rating in a report on Friday, August 21st. Wall Street Zen downgraded AdvanSix from a "hold" rating to a "sell" rating in a research report on Saturday, August 8th. Finally, Truist Financial cut their price target on shares of AdvanSix from $20.00 to $18.00 and set a "hold" rating on the stock in a research note on Monday, August 10th. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Reduce" and a consensus target price of $21.50.
View Our Latest Stock Analysis on AdvanSix
About AdvanSix
(
Free Report)
AdvanSix, Inc NYSE: ASIX is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.
The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.